Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

New insights could lead to better treatments for Dravet syndrome and related conditions

Children with Dravet syndrome, a severe form of epilepsy that begins in infancy, experience seizures, usually for their entire life.

27 Apr 2022

Study examines whether having MS plays a role in regular cancer screenings and diagnosis

Women with multiple sclerosis (MS) are less likely to have breast cancers detected through cancer screenings than women without MS, according to new research published in the April 27, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

27 Apr 2022

Prevalence of multiple sclerosis in Black and white people is similarly high, study says

The rate of multiple sclerosis (MS) cases varies greatly by race and ethnicity. A new study suggests that the prevalence of MS in Black and white people is similarly high, while much lower in Hispanic and Asian people.

27 Apr 2022

Einstein researchers receive $4.2 million NIH grant to detect behavioral markers for Alzheimer's

Diagnosing Alzheimer's disease can be a complex and time-consuming process, requiring evaluations ranging from brain scans to cognitive and lab tests to reviews of medical history and symptoms.

27 Apr 2022

New insights into the link between EMFs, calcium and Alzheimer’s disease

For almost a quarter of a century, researchers have been studying and publishing on the effect of calcium on Alzheimer's Disease. Research has led to the development of the calcium hypothesis of Alzheimer's disease, which argues that Alzheimer's is caused by excessive intracellular calcium.

26 Apr 2022

New discovery about nature’s ‘high-end machinery’ could have big implications for biology

Working with tiny bacteria, Michigan State University researchers led by Lee Kroos have made a discovery that could have big implications for biology.

26 Apr 2022

Researchers develop new platform capable of mitochondrial DNA editing

Researchers from the Center for Genome Engineering within the Institute for Basic Science developed a new gene-editing platform called transcription activator-like effector-linked deaminases, or TALED.

25 Apr 2022

Most blood tests to detect Alzheimer’s disease perform inconsistently across racial groups

Three experimental blood tests used to identify people in early stages of Alzheimer's disease perform differently in Black individuals compared to white individuals, according to a new study from Washington University School of Medicine in St. Louis.

21 Apr 2022

People who accumulate cardiovascular risk factors quickly have higher risk of developing dementia

Cardiovascular disease risk factors, like high blood pressure, diabetes, obesity and smoking, are believed to play key roles in the likelihood of developing cognitive decline, dementia, and Alzheimer's disease.

21 Apr 2022

Researchers discover more needles in the haystack in the quest to unravel Alzheimer’s disease

21 million. That's the number of genetic variations in the human genome that researchers are sifting to identify patterns predisposing people to Alzheimer's disease.

20 Apr 2022

Single-cell genome sequencing provides a new way to think about Alzheimer’s disease

Alzheimer's disease is marked by a loss of functional neurons in the brain. But what causes this loss? Through single-cell genome sequencing, researchers at Boston Children's Hospital, Brigham and Women's Hospital, and the Broad Institute show that people with Alzheimer's have an abundance of newly acquired mutations in their neurons - more than people of the same age without Alzheimer's, and enough to disable genes important to brain function.

20 Apr 2022

'Epigenetic age' can predict performance on cognitive tests later in life

Epigenetic markers of cognitive aging can predict performance on cognitive tests later in life, according to a study published in the journal Aging.

20 Apr 2022

Einstein Aging Study secures $32 million NIH grant to help address the rising tide of Alzheimer's disease

To help address the rising tide of Alzheimer's disease nationwide, researchers at Albert Einstein College of Medicine in collaboration with faculty at Pennsylvania State University and other institutions, have received a five-year, $32 million grant from the National Institutes of Health to support the ongoing Einstein Aging Study, which focuses on both normal aging and the special challenges of Alzheimer's disease, and other dementias. EAS was established at Einstein in 1980 and has been continuously funded by the NIH.

20 Apr 2022

Five different diseases attack language areas in the brain that cause primary progressive aphasia

There are five different diseases that attack the language areas in the left hemisphere of the brain that slowly cause progressive impairments of language known as primary progressive aphasia (PPA), reports a new Northwestern Medicine study.

20 Apr 2022

Type I interferon found to be major driver of memory, cognitive loss in Alzheimer's disease mouse model

Alzheimer's disease (AD), the most common type of dementia, progressively impairs memory, concentration and the ability to learn new things and accomplish everyday activities.

19 Apr 2022

Levels of little-studied enzyme found to decline with age and more dramatically with Alzheimer’s

A little-studied enzyme has been found in high levels in healthy neurons, levels that scientists say decline with age and more dramatically with Alzheimer's, making adjusting the enzyme's level a potential treatment for both.

19 Apr 2022

New insight into neuropsychiatric symptoms in people with Alzheimer’s disease

In addition to memory problems and other cognitive symptoms, most people with Alzheimer's disease also suffer from mental health issues.

19 Apr 2022

Washington state retools first-in-the-nation long-term care benefit

Patricia Keys, 71 and a stroke survivor, needs help with many everyday activities, such as dressing and bathing. Her daughter Christina, who lives near her mom in Vancouver, Washington, cares for her in the evenings and pays about $3,000 a month for help from other caregivers.

18 Apr 2022

Inhibiting key signaling pathway in immune cells may slow down Alzheimer's disease

Inhibiting an important signaling pathway in brain-resident immune cells may calm brain inflammation and thereby slow the disease process in Alzheimer's and some other neurodegenerative diseases, suggests a study by Weill Cornell Medicine investigators.

14 Apr 2022

Chronic tiredness in people with sleep apnea can have serious implications for road safety

Up to half of older adults may have sleep apnea, a condition in which breathing and sleep are briefly interrupted many times a night.

14 Apr 2022

Alzheimer's Disease News and Research

Further Reading

New insights could lead to better treatments for Dravet syndrome and related conditions

Study examines whether having MS plays a role in regular cancer screenings and diagnosis

Prevalence of multiple sclerosis in Black and white people is similarly high, study says

Einstein researchers receive $4.2 million NIH grant to detect behavioral markers for Alzheimer's

New insights into the link between EMFs, calcium and Alzheimer’s disease

New discovery about nature’s ‘high-end machinery’ could have big implications for biology

Researchers develop new platform capable of mitochondrial DNA editing

Most blood tests to detect Alzheimer’s disease perform inconsistently across racial groups

People who accumulate cardiovascular risk factors quickly have higher risk of developing dementia

Researchers discover more needles in the haystack in the quest to unravel Alzheimer’s disease

Single-cell genome sequencing provides a new way to think about Alzheimer’s disease

'Epigenetic age' can predict performance on cognitive tests later in life

Einstein Aging Study secures $32 million NIH grant to help address the rising tide of Alzheimer's disease

Five different diseases attack language areas in the brain that cause primary progressive aphasia

Type I interferon found to be major driver of memory, cognitive loss in Alzheimer's disease mouse model

Levels of little-studied enzyme found to decline with age and more dramatically with Alzheimer’s

New insight into neuropsychiatric symptoms in people with Alzheimer’s disease

Washington state retools first-in-the-nation long-term care benefit

Inhibiting key signaling pathway in immune cells may slow down Alzheimer's disease

Chronic tiredness in people with sleep apnea can have serious implications for road safety

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News